A detailed history of Geode Capital Management, LLC transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 784,129 shares of SGHT stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
784,129
Previous 771,420 1.65%
Holding current value
$3.12 Million
Previous $5.15 Million 3.98%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.49 - $8.31 $69,772 - $105,611
12,709 Added 1.65%
784,129 $4.94 Million
Q2 2024

Aug 09, 2024

BUY
$5.13 - $7.15 $974,951 - $1.36 Million
190,049 Added 32.69%
771,420 $5.15 Million
Q1 2024

May 13, 2024

BUY
$4.02 - $5.89 $65,445 - $95,889
16,280 Added 2.88%
581,371 $3.07 Million
Q4 2023

Feb 13, 2024

BUY
$1.29 - $5.86 $44,882 - $203,886
34,793 Added 6.56%
565,091 $2.92 Million
Q3 2023

Nov 13, 2023

BUY
$2.88 - $8.8 $125,579 - $383,715
43,604 Added 8.96%
530,298 $1.79 Million
Q2 2023

Aug 11, 2023

BUY
$7.46 - $10.67 $51,444 - $73,580
6,896 Added 1.44%
486,694 $4.03 Million
Q1 2023

May 15, 2023

BUY
$8.44 - $13.35 $105,702 - $167,195
12,524 Added 2.68%
479,798 $4.19 Million
Q4 2022

Feb 13, 2023

BUY
$5.58 - $13.94 $53,501 - $133,656
9,588 Added 2.09%
467,274 $5.71 Million
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $843,837 - $1.58 Million
138,334 Added 43.32%
457,686 $2.91 Million
Q2 2022

Aug 12, 2022

BUY
$6.61 - $11.99 $89,472 - $162,296
13,536 Added 4.43%
319,352 $2.87 Million
Q1 2022

May 13, 2022

BUY
$11.56 - $17.9 $1.3 Million - $2.02 Million
112,794 Added 58.44%
305,816 $3.54 Million
Q4 2021

Feb 11, 2022

BUY
$17.36 - $27.36 $222,138 - $350,098
12,796 Added 7.1%
193,022 $3.39 Million
Q3 2021

Nov 12, 2021

BUY
$22.34 - $39.1 $4.03 Million - $7.05 Million
180,226 New
180,226 $4.09 Million

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $190M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.